Lpl Financial LLC Vascular Biogenics Ltd. Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $2.1 $2,253 - $31,550	-15,024 Reduced 14.46%	88,892 $14,000
Q2 2022 Aug 12, 2022	SELL	$1.22 - $1.95 $8,540 - $13,650	-7,000 Reduced 6.31%	103,916 $167,000
Q1 2022 May 16, 2022	BUY	$1.15 - $1.97 $13,500 - $23,127	11,740 Added 11.84%	110,916 $187,000
Q4 2021 Feb 14, 2022	BUY	$1.92 - $2.53 $11,520 - $15,179	6,000 Added 6.44%	99,176 $195,000
Q3 2021 Nov 15, 2021	SELL	$1.94 - $2.55 $15,520 - $20,400	-8,000 Reduced 7.91%	93,176 $191,000
Q2 2021 Aug 13, 2021	BUY	$1.69 - $2.67 $89,867 - $141,979	53,176 Added 110.78%	101,176 $242,000
Q1 2021 May 14, 2021	BUY	$1.79 - $2.91 $85,920 - $139,680	48,000 New	48,000 $96,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.